Yüklüyor......
Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer
Pancreatic cancer is one of the most lethal types of malignant solid tumor and is typically associated with a poor prognosis. The majority of patients are diagnosed with advanced-stage disease, therefore, the median survival period is <6 months. Recently, a number of basic research projects and c...
Kaydedildi:
| Yayımlandı: | Oncol Lett |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734067/ https://ncbi.nlm.nih.gov/pubmed/26893699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.4009 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|